Hana Pharm. Co., Ltd.
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
293480 | KO
Overview
Corporate Details
- ISIN(s):
- KR7293480000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약단지로 13-39, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Hana Pharm Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and distribution of specialty medicines. The company has a strong focus on anesthetics and narcotic analgesics, offering a comprehensive product portfolio that also includes antiemetics and antibiotics. Operating both domestically in South Korea and internationally, Hana Pharm is committed to innovation and quality, with significant investment in Good Manufacturing Practice (GMP) facilities. Its research and development pipeline includes novel products such as Byfavo Inj., an ultra-short-acting anesthetic and sedative, and a new multi-functional MRI contrast medium. The company went public in 2018 and continues to expand its market presence through ongoing research and strategic product development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-04 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 7.1 KB | ||
| 2025-08-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 83.8 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-07-23 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 8.3 KB | ||
| 2025-07-23 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2025-06-17 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-04-23 00:00 |
Regulatory News Service
신규시설투자등
|
Korean | 8.4 KB | ||
| 2025-03-24 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.8 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 11.4 KB | ||
| 2025-03-14 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 501.3 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 158.7 KB | ||
| 2025-02-28 00:00 |
Remuneration Information
기타경영사항(자율공시)
|
Korean | 5.1 KB | ||
| 2025-02-21 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.6 KB | ||
| 2025-02-21 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 9.0 KB |
Automate Your Workflow. Get a real-time feed of all Hana Pharm. Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hana Pharm. Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hana Pharm. Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
